Results 191 to 200 of about 180,408 (257)

Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. [PDF]

open access: bronze, 1996
Constance Barazzone   +4 more
openalex   +1 more source

Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Inflammation in atherosclerotic cardiovascular disease. Residual inflammatory risk (RIR), defined by high‐sensitive C‐reactive protein (hsCRP) concentration of ≥2 mg/L, represents a strong predictor of future atherosclerotic cardiovascular disease (ASCVD) events. Although increased hsCRP values ≥2 mg/L might be detected in every three out of five ASCVD
Natalie Arnold, Wolfgang Koenig
wiley   +1 more source

Soluble-fibre concentrate lowers plasminogen activator inhibitor-1 in baboons (Papio ursinus) [PDF]

open access: bronze, 1997
C S Venter   +10 more
openalex   +1 more source

Circadian misalignment disrupts biomarkers of cardiovascular disease risk and promotes a hypercoagulable state

open access: yesEuropean Journal of Neuroscience, Volume 60, Issue 7, Page 5450-5466, October 2024.
We studied the impact of circadian misalignment on 238 plasma proteins linked to cardiovascular physiology. We identified 42 proteins with altered abundance, five proteins regulated by the circadian clock, and changes in many proteins in the coagulation pathway.
Andrew W. McHill   +3 more
wiley   +1 more source

Obesity, white adipose tissue and cancer

open access: yesThe FEBS Journal, EarlyView.
White adipose tissue (WAT) is essential for energy balance and hormone regulation. In obesity, WAT becomes dysfunctional, leading to inflammation and other changes that promote different stages of carcinogenesis. This review explores how unhealthy WAT under obese conditions supports carcinoma growth through both systemic effects and modulation of the ...
Estel Solsona‐Vilarrasa   +1 more
wiley   +1 more source

Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease. [PDF]

open access: bronze, 1997
F O Akenami   +3 more
openalex   +1 more source

Activation of the Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor System in Periodontitis: A Case–Control Study

open access: yesInternational Journal of Dental Hygiene, EarlyView.
ABSTRACT Introduction The plasminogen activating (PA) system has a multitude of functions such as wound healing, proteolytic activity, collagen degradation and cell growth, and the role of the urokinase plasminogen activator/urokinase plasminogen activator receptor (uPA/uPAR) system has been studied in many disease states.
Ahmed Khudhur   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy